Covalent anti-HIV compound that induces HIV-1 capsid multimerization and degradation, decomposes the viral core
The study reports that ACAi-001, a novel covalent HIV-1 capsid inhibitor identified through in silico screening, uniquely induces aberrant capsid multimerization and degradation by binding to specific residues, thereby disrupting viral core integrity and inhibiting HIV-1 replication.